World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 4.103

ICV : 56.51

Abstract

A COMPARATIVE STUDY OF ‘RAKTASHODHAK GHANA VATI’ AND ‘MUKHKANTIKARA LEPA’ WITH VAMAN KARMA IN THE MANAGEMENT OF YUVANPIDIKA ACNE VULGARIS

Dr. Raghubala Kaviya*, Dr. Brahmanand Sharma and Dr. Anamika Soni

ABSTRACT

Introduction: The face is the index of the mind and the mirror of the body. Yuvanpidika harms beauty of the face so person may suffer with inferiority complex, anxiety, isolation etc. Thus, Yuvanpidika is a painful condition for body as well as for mind too. It affects 85% of teenagers. Due to wide spectrum of disease, much prevalence in the society and lack of effective medicine, the disease is being chosen for the study. Aims and Objectives: To Study the „Raktshodhak Ghana Vati?, „Mukhkantikara lepa? and „Vaman Karma? in the management of „Yuvanpidika? W.S.R. to Acne vulgaris. Methods and Material: Group A – 20 clinically diagnosed and registered patients of ‘Yuvanpidika’ will be treated by ‘Raktshodhak Ghan Vati’ & ‘Mukhkantikar lepa’, 2 tablets two times in a day with lukewarm water, after meal for 45 days. Group B – 20 clinically diagnosed and registered patients of ‘Yuvanpidika’ will be treated with ‘Vaman karma’ followed by treatment with ‘Raktshodhak Ghan Vati’ & ‘Mukhkantikara lepa’, 2 tablets two times in a day with lukewarm water, after meal for 30 days. (Total -15 + 30 = 45 days) Study Design- Single centre and Open Clinical study. Results: In group A Excellent relief was found in 40% of patients, Significant relief in 25%, and Moderate relief was found in 35% of patients. While in group-B, Excellent relief was found in 35% of patients, Significant relief in 15%, Moderate relief in 40%, No relief found in 10% of patients. Conclusions: On comparing the effect of two groups it can be concluded that GroupB („Vaman karma? followed by treatment with „Raktshodhak Ghana Vati? & „Mukhkantikara lepa?) provided better relief than Group A(„Raktshodhak Ghana Vati? & „Mukhkantikara lepa?) in most of the sign and symptom of the disease at significant level.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR